Skip to content

Taking the Pain Out of Blood Collection

YourBio Heath is a medical device company dedicated to improving the blood draw experience.

Get in Touch

Our team designed and developed Touch Activated Phlebotomy (TAP®), the world’s first push-button blood collection technology that enables TAP® Micro and TAP® Micro Select devices to make the blood sampling process simple, convenient, and virtually painless.

Touch Activated Phlebotomy (TAP®) Devices

Our TAP® devices produce high-quality, whole blood samples of up to 900µL through push-button activated, virtually painless capillary blood collection. Our devices facilitate opportunities to replace traditional phlebotomist-conducted venous blood collection or painful fingerstick tests in many collection applications.

HALO™ Technology

With microneedles thinner than an eyelash, HALO™ technology enables TAP® devices to deliver a virtually painless blood collection experience compared to fingerstick, venipuncture, and competitive products.

  • Discover how the proprietary HALO™ Technology enables virtually painless blood draws Learn More

Our Results Speak for Themselves

Up to 900µL of Whole Capillary Blood

Our HALO™ Technology enables patients to collect up to 900µL of blood, accommodating a broad range of standard blood tests1

Up to 99% Collection Success Rate

Our devices are end-user preferred, virtually painless, and yield up to a 99% collection success rate2

200% Increase in Patient Retention/Completion Rates in Clinical Trials

Significantly higher completion rates in clinical trials when compared to fingerstick3

98% of Patients Would Repeat Self-Collection

When asked if they would repeat their self-collection experience with TAP® Micro, 98% of patient respondents responded “yes”4

High Venous Concordance

For broad-based tests, such as cholesterol, capillary blood samples collected in both an assisted and self-collection setting have high concordance with venous blood5

Transformative Impact for Patients

Patients go to the doctor more than 1 billion times a year in the US alone to have their blood drawn with a needle6, which requires an in-person interaction and often causes anxiety and discomfort for the patient.

Now, patients can simply place the device on their upper arm and begin collecting blood with the press of a button. This innovation is a game-changer for the healthcare system, and while we feel TAP® devices will improve patients’ lives in multiple arenas, this approach has strong applications for:

Clinical Trial Support

By enabling patients to draw up to 900µL of blood virtually pain-free remotely, our TAP® devices offer significant advantages for drug sponsors seeking to conduct decentralized trials.

Learn More
Wellness Testing

Incorporating TAP® devices into wellness kits helps wellness innovators improve customer loyalty and enhance feedback thanks to the devices’ ability to enable a virtually pain-free blood test at home.

Learn More
Clinical-Grade Blood Sampling

TAP® Micro Select enables providers to conveniently produce whole capillary blood that has high concordance with venous blood6.

Learn More

Latest Research and Highlights

Discover the latest studies and reports published on our devices and solutions

View All
  • July 15, 2024
    Longer interval between maternal RSV vaccination and birth increases placental transfer efficiency

    TAP was employed to collect capillary blood from 2-month-old infants for antibody tests of RSV and pertussis toxin.

    Read More
  • July 1, 2024
    Feasibility, reliability and satisfaction of (automated) capillary carcinoembryonic antigen measurements for future home-based blood sampling: the prospective CASA-I study
    Colorectal Disease

    Feasibility of home-based capillary sampling of colorectal cancer marker CEA was demonstrated. TAP was found to be “the most reliable method and is preferred by patients over venipuncture and lancet sampling.” (Erasmus MC)

    Read More
  • April 11, 2024
    Evaluation of a hybrid telehealth care pathway for patients with axial spondyloarthritis including self-sampling at home: results of a longitudinal proof-of-concept mixed-methods study (TeleSpactive)
    Rheumatology International

    TAP was employed to demonstrate the feasibility, high patient acceptance, and overall potential of a scalable axSpA hybrid telehealth care pathway.

    Read More
View All
References
  1. Citation: Internal data.
  2. Citation: This is a customer-reported statistic.
  3. Citation: This is a customer-reported statistic.
  4. Citation: Internal data.
  5. Citation: Collier, B. B., Brandon, W. C., Chappell, M. R., Kovach, P. M. & Grant, R. P. Maximizing Microsampling: Measurement of Comprehensive Metabolic and Lipid Panels Using a Novel Capillary Blood Collection Device. J. Appl. Lab. Med. jfad066 (2023) doi:10.1093/jalm/jfad066.
  6. Citation: Leipheimer JM, Balter ML, Chen AI, Pantin EJ, Davidovich AE, Labazzo KS, Yarmush ML. First-in-human evaluation of a hand-held automated venipuncture device for rapid venous blood draws. Technology (Singap World Sci). 2019 Sep-Dec;7(3-4):98-107. doi: 10.1142/S2339547819500067. Epub 2020 Jan 22. PMID: 32292800; PMCID: PMC7156113.